Reagents (antibodies) used in this study and certain methods [cell culture, transfections, western blotting, immunocytochemistry, and antisense (AS)] may be found in Supporting Methods, which is published as supporting information on the PNAS web site.
Tumor necrosis factor (TNF) ␣ and mitogen-activated protein kinase͞ c-Jun N-terminal kinase (MAPK͞JNK) pathways are both implicated in Alzheimer's disease (AD) pathogenesis. Increased expression of several members of the TNF pathway and JNK activation of c-Jun ultimately result in neuronal apoptosis. DENN͞MADD, a multifunctional domain protein expressed in neurons, interacts with both the p55 TNF receptor (TNFR) type 1 and JNK3, placing it at a critical juncture in regulating signaling of neurodegeneration. We examined expression and interactions of the TNFR1 binding proteins, DENN͞ MADD, and TNFR-associated death domain (TRADD) protein in ADaffected tissues and cell cultures. We found reduced DENN͞MADD and increased TRADD expression immunohistochemically in the hippocampus in areas of AD pathology compared to normal controls but little intraneuronal colocalization. In brain homogenates, DENN͞ MADD protein and mRNA expression was significantly reduced in AD compared to controls. Conversely, TRADD, TNFR1, and activated JNK were increased. Murine neuroblastoma and rat hippocampal cultures stressed with A␤1-42 and the cortices of AD transgenic mice (Tg2576Swe) each showed decreased DENN͞MADD expression and TRADD up-regulation in the mice, compared to controls. DENN͞ MADD antisense treatment of cultured rat hippocampal neurons reduced endogenous DENN͞MADD and promoted neuronal cell death. DENN͞MADD and TRADD competitively bound to TNFR1 when overexpressed in N2A cells, with DENN͞MADD abrogating TNFR1 binding to TRADD. DENN͞MADD may therefore be protective by inhibiting TRADD-induced apoptotic cell death. Reduction of DENN͞ MADD may affect long-term neuronal viability in AD by allowing TRADD mediation of TNFR1 signaling in response to oxidative or cytokine-promoted stresses. amyloid ͉ apoptosis A lzheimer's disease (AD) is characterized by gradual deposition of beta amyloid (A␤), neurofibrillary tangle (NFT) pathology, loss of synaptic terminals, progressive dementia, and neuronal cell death (1) (2) (3) . Multiple signaling pathways have been implicated in AD progression. Cross-talk between the tumor necrosis factor (TNF) ␣ and mitogen-activated protein kinase͞ c-Jun N-terminal kinase (MAPK͞JNK) pathways potentially provides a cell death mechanism in the chronic setting of AD.
While the TNF receptor (TNFR) pathway contributes to the progression of neuronal cell death in AD, Parkinson's disease, and stroke (4-7), A␤ fibril formation in AD brains induces microglial͞ monocytic activation and TNF-␣ production (8) . TNF-␣ signals through either of two receptors, p55 TNFR1 or p75 TNFR2 (9, 10). TNF-mediated signaling involving recruitment or inhibition of adapter components may ultimately affect neuronal fate. Binding of TNFR-associated death domain (TRADD) protein and DENN (differentially expressed in normal versus neoplastic)͞MADD (MAPK activating death domain) protein to TNFR1 occurs through death domain (DD) interactions (10, 11) . TNFR1 activation promotes binding of TRADD and subsequent recruitment of Fas-associated death domain (FADD) protein, receptor-interacting protein (RIP), or TNFR-associated factor (TRAF2) to promote apoptosis, JNK activation, and NF-B activation. The resulting death-inducing signaling complex (DISC) eventually determines apoptotic transduction or cell survival. TNFR1 triggers the NF-B signaling pathway via recruitment of the IKK complex (12), whereas JNK is activated via TRAF2-mediated activation of apoptosis signaling kinase (ASK1) (13) .
Expression of various components of TNF, JNK, and caspase pathways have been determined in the AD-affected brain and in neuronal cultures (14) (15) (16) . TNF-␣ is up-regulated in the AD brain and proinflammatory cytokines, such as TNF-␣ with IFN, induce production of A␤1-42 in neurons (17) . A␤ activates JNK and induces apoptosis in neuronal cultures (18) (19) (20) , and is up-regulated in AD (3). Activation of caspase-8 and caspase-3 also occurs in the AD brain and in neuronal cultures incubated with A␤ (14, 21) .
Down-regulation of TNF pathway proteins is observed in the AD-affected brain, including FADD-like IL-1␤-converting enzyme (FLICE) inhibitor protein (FLIP) and TNFR2 (14, 15) . These factors potentially promote neuroprotective mechanisms, involving the TNFR pathway. FLIP interacts with TRADD and blocks caspase-8 recruitment (22) , and TNFR2 plays a trophic or protective role in neuronal survival (23, 24) . Recently, Micheau and Tschopp (25) reported that a complex involving TNFR1, TRADD, RIP, and TRAF2 dissociates rapidly on posttranslational modification and binds FADD and caspase-8 to initiate apoptosis ( Fig. 2 A) . Furthermore, A␤ induces cell death via a FADD-mediated pathway potentially linking A␤-induced neuronal apoptosis to death receptors of the Fas͞TNFR family (21) .
To translate acute responses of DENN͞MADD and TNFR1related proteins in experimental models to the disease state, we first examined the AD-affected CNS, which is chronically exposed to neuroinflammatory and oxidative stresses, such as TNF-␣ and A␤. DENN͞MADD and TRADD expression was correlated with AD pathology and compared with CNS of normal, age-matched controls. Endogenous DENN͞MADD expression was next defined in neuroblastoma and primary hippocampal cultures. DENN͞ MADD interactions with either TNFR1 or TRADD were examined for regulation of apoptosis in transfected neurotypic cultures. Tissue Sources. Human CNS tissues were obtained from the University of Southern California Alzheimer's Disease Research Center. Neuropathological examination confirmed AD, using modified criteria of the Consortium to Establish a Registry for Alzheimer's Disease (CERAD) (27) and the National Institute of Aging Reagan Institute Consensus Conference (28) , and Braak staging (1). Blocks (1 cm 3 ) were obtained from hippocampi at autopsy and either immediately fixed in phosphate-buffered formalin or snap-frozen in liquid nitrogen chilled isopentane. Patients were cognitively assessed longitudinally. Neuropathological evaluation included nine cognitively normal age-matched controls by Clinical Dementia Rating (CDR) and two patients with CDRs of 0.5 evaluated every 6 months. Neuropathological evaluation of this group included Braak and Braak scores of 0-III and CERAD scores of 0-1 (absent to sparse) [mean ages, 86.6 Ϯ 6.2; gender, eight females and three males; mean postmortem interval (PMI), 6.6 h]. There were 11 AD patients with CDRs of 2-3 evaluated annually, Braak and Braak scores of V-VI, and CERAD scores of 3-5 (moderate to severe) (mean age, 85.5 Ϯ 7.2; gender, eight females and three males; mean PMI, 5.8 h). Agonal histories excluded terminal hypoxia. For Tg2576 mouse brains, piriform cortex was snap-frozen and stored at Ϫ80°C, and extracts were prepared as described (29) .
Antisense Inhibition of DENN Expression.
Rat hippocampal neurons were grown on poly(L)-lysine-coated wells for 6-8 d in vitro and were transfected with Lipofectin (GIBCO͞BRL). The AS sequences for DENN are JNK binding domain (JBD)-AS 5Ј-CCAGTCTCAAGCTGTTGGGCC-3Ј and DD-AS 5Ј-TGTAG-GAGATGAGGTTGTG-3Ј (31). The control-AS sequence is 5Ј-CCTTGGGAGCTAGCTCTGACC-3Ј.
Results

DENN Expression Is Reduced in AD-Affected Human Hippocampus.
As schematically shown ( Fig. 2 A) , DENN interactions with DDcontaining proteins of the TNF-␣ pathway, including TNFR1 and TRADD, as well as JNK3, suggest a role in transducing cell death (11, 26, 32) . Activation of the TNF and JNK pathways resulting from extracellular stress signals may result from differential expression in AD-affected regions of the human brain compared with normal controls. We examined DENN expression immunohistochemically in human hippocampus obtained from 11 AD and 11 age-matched control patients. In control tissues, pyramidal neurons revealed strong, diffuse staining of the cytoplasm and perinuclear region. Pyramidal neurons and the surrounding neuropil in ADaffected regions of the hippocampus, including CA1, consistently showed less staining than the same region in companion controls ( Fig. 1A ). Glia and vessels showed no immunostaining. Thus, DENN protein expression is reduced in AD-affected neurons.
In addition to DENN interaction with TNFR1, the adapter molecule TRADD binds to TNFR1 and activates the JNK pathway in various cell lines (33, 34) . Confirming observations by Zhao et al. (14) , we found increased TRADD immunostaining of CA1 neurons in AD-affected tissues compared to controls ( Fig. 1 A) , especially in regions of A␤ deposition (Fig. 1B ). There was little specific colocalization of DENN with TRADD in the neuronal cytoplasm of controls or AD tissues (Fig. 1C ).
To determine effects of AD-related neurofibrillary pathology on DENN expression, pyramidal neurons of the human hippocampus were coimmunostained with polyclonal DENN antibody and mAb AT8, which identifies hyperphosphorylated tau. These sites were preselected by verification of A␤ deposits with thioflavin S fluorescence and Gallyas silver stains of adjacent diagnostic tissue blocks (data not shown). Confocal microscopy of the CA1 subregion of normal, age-matched hippocampi found DENN localized to the cytoplasm of pyramidal neurons and the surrounding neuropil ( Fig. 1D ). In AD-affected tissues, neurons contained mAb AT8reactive neurofibrillary tangles (NFTs) in neuronal somata and adjacent neurites. Whereas controls showed minimal neurite stain-ing, DENN expression was markedly diminished both in the neurons and neuropil and especially in NFT-bearing neurons.
DENN Protein Is Down-Regulated and TRADD Is Up-Regulated in AD
Tissue Homogenates. Expression of DENN and other TNFR1associated proteins are shown in Fig. 2A . Total homogenates of human hippocampus were immunoblotted with antibodies specific to each protein. Although AD pathology has a specific topographical distribution, pathologic changes are not uniformly distributed within each region. The variable expression of proteins from patient to patient is reflected on immunoblots. In Fig. 2B , protein expression was compared in hippocampi obtained from four representative age-matched controls and four AD patients. These are representative of hippocampal homogenates compared from 11 controls and 11 AD cases. Overall, 10 of 11 AD patients showed reduced DENN expression on Western blots compared with controls, and 8 of 11 AD patients had increased TRADD expression (data not shown). DENN showed a 15-fold decrease in protein expression in AD relative to controls. JNK3, a neuronal specific kinase, and the largest neurofilament protein, NF200, each revealed relatively stable expression in both AD and controls, suggesting that the decrease in DENN expression was not likely a result of neuronal loss.
We further probed immunoblots of hippocampal homogenates with antibodies specific to proteins of the TNF-␣ pathway: TRADD, TNFR1, RIP, TRAF2, and FADD. Densitometry indicated a 2.5-fold increase of TRADD expression, 2-fold increase of TNFR1, 4-fold decrease of TRAF2, and unchanged levels of RIP and FADD (Fig. 2B) . Comparison of the densitometric averages of expression were statistically significant between AD and controls (P Ͻ 0.05, ANOVA). Tissue from two patients with the most enhanced TRADD expression, AD3 and AD4, also had the most histologically abundant neuritic plaques as assessed by CERAD criteria. Amyloid precursor protein (APP) expression was also up-regulated in AD brains (data not shown). The phosphorylated form of JNK was increased 10-fold in AD as reported by Zhu et al. (35) . Moreover, we did not observe any significant changes in DENN expression in cerebellum (data not shown), a region free of AD pathology. These results suggest regulation of DENN and TRADD expression may govern the balance of downstream TNFR1 signaling events.
DENN mRNA Is Down-Regulated in AD.
To examine endogenous DENN mRNA expression in an environment of long-term A␤ accumulation and oxidative stress, tissues from AD patients were compared to controls. RT-PCR of hippocampal tissues from two age-matched controls and five AD patients revealed dramatically reduced DENN expression in AD tissues, whereas ␤-actin remained at similar levels in both control and AD (Fig. 2C ). In cerebellum, there was little difference in DENN mRNA expression in AD compared to controls (data not shown). These results further suggest reduced DENN expression correlates with AD pathogenesis.
A␤ Peptide Decreases DENN Expression in Neuronal
Cultures. A␤ is selectively neurotoxic to a variety of neuronal subpopulations, including cells of the neocortex and hippocampus, as well as clonal neuronal cell lines (20, 36, 37) . To extrapolate our findings from the human CNS, the impact of A␤ exposure on endogenous DENN expression was investigated in vitro, in primary CNS neuronal cultures and in neuroblastoma cells. In Fig. 3A , primary rat hippocampal cultures were exposed to 25 M fibrillar A␤1-42 for 24 h (19) and stained with antibodies specific to DENN and phosphorylated JNK (P-JNK). Confirming the observation of Coffey et al. (38) , A␤ induced translocation of P-JNK to the nucleus. DENN colocalized with P-JNK in the cytoplasm and processes of control neurons but was diminished in the processes after A␤ exposure. Western immunoblotting of extracts prepared from hippocampal neurons exposed to A␤ for 0, 1, 2, 3, and 4 d showed decreased expression of DENN as early as day 1 (Fig. 3B) .
Immunoblots of NSC19 and N 2 A cultures indicated that expression of endogenous DENN protein was significantly decreased by A␤ exposure (Fig. 3C) . In untreated cultures, NSC19 cells expressed 3-fold more DENN relative to N 2 A, but ␤-actin was expressed in equivalent amounts in both cell lines regardless of A␤ exposure. Interestingly, TRADD expression in NSC19 and N 2 A cultures was close to threshold and did not change significantly with A␤ exposure (data not shown).
RNA expression was compared in A␤-exposed and untreated N 2 A cells (Fig. 3D ). Using DENN gene-specific primers, RT-PCR produced a 452-bp product. In representative samples, a 4-fold reduction in DENN expression compared to controls was confirmed by densitometry. RT-PCR of ␤-actin remained constant and c-Jun increased, indicating that the reduction in DENN RNA was were analyzed by 4 -15% gradient SDS͞PAGE, transferred to a poly(vinylidene difluoride) membrane, and probed with antibodies specific for DENN, TRADD, TNFR1, TRAF2, RIP, JNK3, P-JNK, and NF200. Anti-DENN detects a specific band at 200 kDa, the predicted molecular weight of DENN, which is reduced in AD hippocampus. Increased expression of the 34-kDa TRADD protein and the 55-kDa TNFR1 protein in AD contrasts with expression of RIP, FADD, and JNK3, which remain constant in both control and AD tissues. TRAF2 expression is similarly decreased in AD, whereas activated JNK (P-JNK) is increased and NF200 expression remains constant, suggesting neuronal distribution is similar in both control and AD. (C) RT-PCR of total RNA pooled from the hippocampi of two age-matched controls and five AD patients were amplified by using primers specific for DENN or ␤-actin. The amplified product is a 452-bp region spanning the N-terminal region of DENN. DENN mRNA is significantly reduced in AD hippocampus, whereas ␤-actin levels are constant. not a result of a general decrease of transcriptional activity in the presence of JNK activation (39) .
DENN Expression Is Reduced in Tg2576 APP-Overexpressing Mice.
To relate our findings in neuronal cultures to an animal model of AD, we examined mouse cortical extracts from 22-month-old controls and APP-overexpressing mice (n ϭ 2, each set). Antibodies specific to DENN and TRADD revealed down-and up-regulation, respectively ( Fig. 3E ). Up-regulation of cytokines, including TNF-␣, in Tg2576 mouse brains (40) may lead to increased TRADD expression. In the context of DENN down-regulation, Tgϩ mice showed increased APP and P-JNK expression, whereas ␤-actin remained unchanged (Fig. 3E) . (Fig. 4B) .
DENN-AS treatment resulted in increased cell death in hippocampal neurons. DAPI staining revealed pyknotic nuclei and condensed chromatin (Fig. 4C) . Terminal deoxynucleotidyltransferase-mediated dUTP nick end labeling (TUNEL) further showed Cell extracts (100 g) were immunoblotted with DENN antibody and reprobed with ␤-actin. DENN-reactive band at 200 kDa is decreased after A␤ exposure. NSC19 expression of DENN is greater than in N 2A cells. Actin control is unchanged. Similar results were obtained in three independent experiments. (D) Total RNA from control (C) and 25 M A␤1-42 exposed N2A cultures was extracted, followed by RT-PCR using either DENN or primers specific to ␤-actin or c-Jun. RNA levels of DENN are reduced in A␤-exposed cultures, whereas actin levels are comparable to controls and c-Jun is increased. Results are representative of three independent experiments. (E) Piriform cortical protein extracts were prepared from Tg2576Swe mice (aged 22 months, n ϭ 2, wild type) TgϪ. Samples (50 g) were immunoblotted with antibodies specific for DENN, TRADD, APP, P-JNK, or ␤-actin. DENN expression was decreased and TRADD expression increased in transgenic positive (Tgϩ) mice along with increased APP and P-JNK expression. Note that equal protein applied per sample is indicated by constant ␤-actin. 
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selectively increased cell death in neurons with depleted DENN expression, whereas remaining neurons expressing normal levels of DENN were not TUNEL positive (Fig. 4C ). Quantification of TUNEL-positive neurons showed DENN-AS treatment resulted in 25% and 40% survival with DENN-JBD and DENN-DD AS, respectively (Fig. 4D) . Thus, DENN expression is essential for cell survival of hippocampal neurons.
Competition Between DENN and TRADD May Alter Neuronal Cell
Death. To determine the consequence of relative levels of either TRADD or TNFR1 on interactions with DENN, we coexpressed TNFR1, myc-tagged TRADD, and GFP-tagged DENN, in N 2 A cells, as well as either TRAF2 or FADD. Extracts were immunoprecipitated with antibodies specific to TNFR1, myc, TRAF2, or FADD and immunoblotted with anti-GFP to determine binding of DENN. In Fig. 5A , DENN is immunoprecipitated by TNFR1, TRADD, and TRAF2 but not FADD. When TNFR1, DENN, and TRADD are coexpressed, there was a 3-fold reduction in DENN binding to TRADD. DENN expression was equivalent in all samples when probed with anti-DENN ( Fig. 5A, lower blot) . Furthermore, TRADD was immunoprecipitated by TNFR1, DENN, and TRAF2 and weakly with FADD ( Fig. 5B ). However, coexpression of DENN with TNFR1 and TRADD resulted in abrogation of TNFR1 and TRADD interactions (Fig. 5B ). Immunocytochemically, DENN colocalized in N 2 A cells with the TNFrelated factors, TNFR1, TRADD, and TRAF2, as well as with JNK3, but not with FADD ( Fig. 5C ). In Fig. 5D , DENN coexpression with TRADD and TNFR1 partially blocked TRADD-induced apoptosis compared to TRADD coexpression with either TNFR1 or DENN (P Ͻ 0.05, ANOVA). Taken together with the inhibition of binding of TRADD with TNFR1 demonstrated in Fig. 5B , DENN complex formation with TNFR1, TRADD, and TRAF2 suggests DENN interferes with TRADD signaling and thereby may protect neuronal cells from cell death.
Discussion
The interplay of TNF-␣ and MAPK signaling pathways in neuronal degeneration is reflected in the expression and regulation of key signaling proteins. DENN, a DD-containing protein that binds to TNFR1 and JNK3, showed significant downregulation in AD tissues, but not in normal, age-matched controls. In the AD-affected CA1 region of the hippocampus, DENN expression was diffusely diminished immunohistochemically, and also by western analysis and RT-PCR, especially in areas of A␤ and tau pathology. In CA1 pyramidal neurons adjacent to neurofibrillary tangle (NFT)-bearing cells in the AD hippocampus, DENN accumulated in the perinuclear cytoplasm. These results suggest that neuropathological effects of AD are correlated with DENN expression.
Down-regulation of DENN in response to A␤ exposure of neurotypic and hippocampal cultures suggests that effects observed in AD hippocampus are reproducible in vitro and involve an A␤-mediated pathway. Translocation of residual endogenous DENN expression from neurites to the cytoplasm was coupled with nuclear localization of activated JNK. Protein and RNA expression of DENN was decreased in neuronal cultures. Similarly, in the AD transgenic mouse model Tg2576 (41) , DENN expression was also decreased in extracts of piriform cortices, where APP expression was increased and A␤ plaques numerous (29) .
Several other TNFR1 binding factors revealed altered expression in regions with AD histopathology. TRAF2, which binds TRADD and promotes JNK activation via apoptosis signaling kinase (ASK1), was also decreased in AD tissue. Schievella et al. (11) report that DENN overexpression in nonneuronal culture systems results in activation of both extracellular-regulated kinase (ERK) and JNK. However, because MAPKs are activated in AD (42) , and DENN and TRAF2 are down-regulated, it is not likely that these proteins contribute to JNK-or ERK-mediated cell death or survival pathways.
Interestingly, there was increased expression of other members of the TNF signaling pathway, including TRADD and TNFR1, both in AD tissues and Tg2576 mouse extracts. TRADD overexpression leads to increased cell death of nonneuronal cells (33) , and we confirmed enhanced apoptosis by TRADD overexpression in neuronal N 2 A cultures. TNFR1 expression was also increased in AD tissues, in agreement with Zhao et al. (14) , suggesting receptor involvement in promoting cell death. However, not all TNF signaling factors are affected, because FADD and RIP expression levels remained unchanged in AD-affected tissues.
A␤ effects on protein expression may result in reduced inhibition of cell death signals. Based on results of our in vivo competition assay coexpressing DENN, TRADD, and TNFR1 in N 2 A cells, the strong TNFR1-DENN interaction points to the potential to block TNFR1-TRADD interactions. This mechanism is also suggested by the immunocytochemical overlap of DENN and TRADD overexpressed in N 2 A cells and functionally, with DENN inhibition of TRADD-induced apoptosis. These results provide a significant rationale for DENN reduction leading to cell death in the setting of sustained activation by TNF-␣.
Apoptosis was augmented by anti-sense depletion of DENN expression. DENN expression is therefore required for neuronal survival. Lim and Chow (30) report enhancement of cell death by exposure of mammalian tumor cell lines to DENN-AS, arguing that constitutive threshold levels of DENN are required for cell proliferation. Higher constitutive DENN expression in malignant cells relative to nontransformed cells suggests alteration of DENN activity may disrupt normal cellular proliferation.
Increasing evidence supports an essential function of DENN in Ca 2ϩ -mediated exocytosis and neurotransmitter release (43, 44) . DENN plays a physiologic role as a guanine nucleotide exchange protein (GEP) for Rab3A in synaptic vesicle release in humans, as it does in rodent and Caenorhabditis elegans (43, 45) . DENN up-regulates a postdocking step of synaptic exocytosis. Therefore, the stress-induced relocation of DENN may contribute to reduced neurotransmitter function in neurites, including release of acetylcholine, a known feature in AD (46) . DENN promotes ERK-mediated cell proliferation in Kaposi's sarcoma (KS) cells (47) . TNF-␣-mediated cell proliferation in KS cells couples TNFR1 with the ERK1͞2 signaling pathway via DENN. In HeLa cells stably expressing DENN or its isoforms, ERK1͞2 and NF-B are activated in response to TNF-␣ exposure, suggesting a defined protective or proliferative function for DENN (31) . Overexpression of DENN provides partial resistance to TNF-␣-induced apoptosis and activation of caspase-3 and -8.
DENN reduction in AD correlates with a growing family of proteins involved in the neuroprotective mechanisms of TNF signaling, including FADD-like IL-1␤-converting enzyme (FLICE) inhibitor protein (FLIP) and TNFR2. FLIP binds to FADD and blocks subsequent caspase-8 recruitment and activation. Downregulation thus allows TRADD to induce apoptosis. TNFR2 does not contain a DD and therefore serves a more neuroprotective role in response to TNF-␣ (23).
The identification of key TNFR-related signaling components with altered expression in AD suggests A␤-mediated regulation may affect neuronal survival. Although DENN expression was decreased in the AD hippocampus, TRAF2 also showed diminished expression and in vitro binding to DENN. Speculatively, with TRADD expression increased in the AD-affected CNS and Tg2576 mouse cortex, it is available to bind to TNFR1, suggesting neuronal cell death may be mediated by A␤-induced TNF-␣ induction. In agreement with Micheau and Tschopp (25), multiprotein complexes containing TRADD, TRAF2, RIP, and additional protein factors are released from TNFR1 after TNF-␣ activation and promote downstream apoptotic events. DENN may be a critical factor in these complexes and reduce the potentiation of neuronal cell death.
